NI200700063A - Hexadecasacáridos biotinilados, su preparación y su utilización. - Google Patents

Hexadecasacáridos biotinilados, su preparación y su utilización.

Info

Publication number
NI200700063A
NI200700063A NI200700063A NI200700063A NI200700063A NI 200700063 A NI200700063 A NI 200700063A NI 200700063 A NI200700063 A NI 200700063A NI 200700063 A NI200700063 A NI 200700063A NI 200700063 A NI200700063 A NI 200700063A
Authority
NI
Nicaragua
Prior art keywords
hexadecasacáridos
biotylated
preparation
oso3
alkoxy
Prior art date
Application number
NI200700063A
Other languages
English (en)
Inventor
Philippe Duchaussoy
Jean-Pascal Herault
Jean Marc Herbert
Maurice Petitou
Pierre Savi
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI200700063(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NI200700063A publication Critical patent/NI200700063A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a nuevos hexadecasacáridos biotinilados de fórmula general I en la cual : -Biot es un derivado de biotina; -R, R1 y R2 representan, independientemente uno del otro, un alcoxi-(C1-C6) o un -OSO3; -R3 representa un alcoxi -(C1-C6) o un -OSO3; o bien R3 constituye un puente -O-CH2-; -Pe representa un encadenamiento sacarídico; así como sus sales farmacéuticamente aceptables, y su utilización como medicamentos.
NI200700063A 2004-09-09 2007-02-27 Hexadecasacáridos biotinilados, su preparación y su utilización. NI200700063A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique

Publications (1)

Publication Number Publication Date
NI200700063A true NI200700063A (es) 2008-03-07

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
NI200700063A NI200700063A (es) 2004-09-09 2007-02-27 Hexadecasacáridos biotinilados, su preparación y su utilización.

Country Status (39)

Country Link
US (3) US20070270342A1 (es)
EP (1) EP1791872B1 (es)
JP (1) JP5108519B2 (es)
KR (1) KR101223364B1 (es)
CN (1) CN101039963B (es)
AR (1) AR051286A1 (es)
AT (1) ATE420118T1 (es)
AU (1) AU2005284080B2 (es)
BR (1) BRPI0515078A (es)
CA (1) CA2577258C (es)
CY (1) CY1109126T1 (es)
DE (1) DE602005012287D1 (es)
DK (1) DK1791872T3 (es)
EA (1) EA012587B1 (es)
EC (1) ECSP077272A (es)
ES (1) ES2320576T3 (es)
FR (1) FR2874924B1 (es)
GT (1) GT200500250A (es)
HK (1) HK1113686A1 (es)
HN (1) HN2005000518A (es)
HR (1) HRP20090180T1 (es)
IL (1) IL181569A (es)
MA (1) MA28859B1 (es)
MX (1) MX2007002875A (es)
MY (1) MY140666A (es)
NI (1) NI200700063A (es)
NO (1) NO20071754L (es)
PA (1) PA8644201A1 (es)
PE (1) PE20060663A1 (es)
PL (1) PL1791872T3 (es)
PT (1) PT1791872E (es)
RS (1) RS50762B (es)
SI (1) SI1791872T1 (es)
SV (1) SV2006002221A (es)
TN (1) TNSN07053A1 (es)
TW (1) TW200612970A (es)
UY (1) UY29102A1 (es)
WO (1) WO2006030104A1 (es)
ZA (1) ZA200702255B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ATE190619T1 (de) 1993-09-01 2000-04-15 Akzo Nobel Nv Biskonjugate, die zwei saccharide und einen spacer enthalten
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
US8557968B2 (en) 2013-10-15
SV2006002221A (es) 2006-01-13
PE20060663A1 (es) 2006-08-21
WO2006030104A1 (fr) 2006-03-23
MX2007002875A (es) 2007-05-16
UY29102A1 (es) 2006-04-28
HK1113686A1 (en) 2008-10-10
AU2005284080B2 (en) 2011-10-13
US8703738B2 (en) 2014-04-22
MA28859B1 (fr) 2007-09-03
AU2005284080A1 (en) 2006-03-23
CA2577258C (fr) 2013-05-21
JP2008512538A (ja) 2008-04-24
EA012587B1 (ru) 2009-10-30
ES2320576T3 (es) 2009-05-25
US20130004551A1 (en) 2013-01-03
ZA200702255B (en) 2008-09-25
ATE420118T1 (de) 2009-01-15
RS50762B (sr) 2010-08-31
KR101223364B1 (ko) 2013-01-16
HN2005000518A (es) 2009-06-01
JP5108519B2 (ja) 2012-12-26
EA200700594A1 (ru) 2007-08-31
US20070270342A1 (en) 2007-11-22
GT200500250A (es) 2006-04-10
DK1791872T3 (da) 2009-05-04
EP1791872B1 (fr) 2009-01-07
CN101039963A (zh) 2007-09-19
AR051286A1 (es) 2007-01-03
PT1791872E (pt) 2009-03-27
HRP20090180T1 (en) 2009-05-31
KR20070051887A (ko) 2007-05-18
TW200612970A (en) 2006-05-01
CY1109126T1 (el) 2014-07-02
FR2874924B1 (fr) 2006-12-01
IL181569A (en) 2011-08-31
SI1791872T1 (sl) 2009-06-30
PA8644201A1 (es) 2006-05-16
US20100279960A1 (en) 2010-11-04
DE602005012287D1 (de) 2009-02-26
FR2874924A1 (fr) 2006-03-10
BRPI0515078A (pt) 2008-07-01
IL181569A0 (en) 2007-07-04
CA2577258A1 (fr) 2006-03-23
MY140666A (en) 2010-01-15
NO20071754L (no) 2007-04-02
PL1791872T3 (pl) 2009-06-30
CN101039963B (zh) 2011-07-27
TNSN07053A1 (fr) 2008-06-02
EP1791872A1 (fr) 2007-06-06
ECSP077272A (es) 2007-03-29

Similar Documents

Publication Publication Date Title
NI200700063A (es) Hexadecasacáridos biotinilados, su preparación y su utilización.
PE20090362A1 (es) Derivados de piperidina/piperazina como moduladores de dgat
NO20083726L (no) Spiroindolinon derivater
CY1113736T1 (el) Ετεροαρυλ-ουριες και η χρηση τους ως ενεργοποιητες γλυκοκινασης
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
CR10192A (es) Compuestos de amido y su uso como productos farmaceuticos
ES2421723T3 (es) Análogos de TOFA útiles en el tratamiento de trastornos o afecciones dermatológicas
ECSP088456A (es) Derivados de [4-(benzo[b]tiofen-2-il)pirimidn-2il]-amina como inhibidores ikk-beta para el tratamiento de cancer y enfermedades inflamatorias
CR10662A (es) Compuestos de metilpiridopirimidinona
NO20083910L (no) Forbedret prodroge av CC-1065 analoger
ATE517874T1 (de) Pyrimidinone als modulatoren von caseinkinase ii (ck2)
ECSP088184A (es) Derivados de benzoquinazolina y su uso en el tratamiento de enfermedades óseas
CO6321276A2 (es) Derivados de tiazol usados como inhibidores de pi3- cinasa
UY27946A1 (es) 8-(3-amino-piperidin-1 il)- xantinas, su preparación y su utilización como medicamentos
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20064599L (no) Substituerte morfolin- og tiomorfolinderivater
NO20082159L (no) Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
ECSP066542A (es) Derivados de disulfuro, sulfuro, sulfóxido, y sulfota de azúcares cíclicos y sus usos
EA201070519A1 (ru) Соединения тропана
CO6351740A2 (es) Combinaciones sinergicas de un inhibidor macrociclico del vhc y un nucleosido
AR044650A1 (es) Derivados de tiofeno - pirimidinona y su uso en la terapia de enfermedades que requieren la inhibicion de la enzima 17b-hidroxiesteroide-dehidrogenasa.
UY27774A1 (es) Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
ECSP099062A (es) Derivados novedosos de aminopiridina que tienen acción inhibidora selectiva sobre aurora a